Sequelae of other inflammatory polyneuropathy
ICD-10 G65.1 is a billable code used to indicate a diagnosis of sequelae of other inflammatory polyneuropathy.
Sequelae of other inflammatory polyneuropathy refers to the long-term effects and residual symptoms that persist after the acute phase of an inflammatory polyneuropathy has resolved. Inflammatory polyneuropathies can arise from various causes, including autoimmune disorders, infections, or toxic exposures. The sequelae may manifest as persistent weakness, sensory disturbances, or autonomic dysfunction, significantly impacting the patient's quality of life. Neurological assessments often reveal deficits in motor and sensory function, which may require ongoing rehabilitation and management. Treatment may involve physical therapy, occupational therapy, and medications to manage symptoms such as pain or muscle weakness. Accurate coding of G65.1 is essential for proper reimbursement and to reflect the complexity of care required for these patients.
Detailed neurological assessments, including motor and sensory evaluations, and documentation of treatment plans.
Patients presenting with persistent weakness or sensory loss following an episode of inflammatory polyneuropathy.
Ensure that all sequelae are documented clearly to support the use of G65.1.
Comprehensive rehabilitation plans, including goals and progress notes.
Patients undergoing rehabilitation for functional impairments due to sequelae of inflammatory polyneuropathy.
Document the impact of sequelae on daily activities and quality of life.
Used for patients undergoing rehabilitation for sequelae of inflammatory polyneuropathy.
Documentation of the patient's functional limitations and goals for therapy.
Physical therapy notes should clearly link the exercises to the sequelae.
Common symptoms include persistent weakness, sensory disturbances, and autonomic dysfunction following an episode of inflammatory polyneuropathy.
G65.1 specifically refers to sequelae of inflammatory polyneuropathy, while other codes may refer to acute or unspecified neuropathies.
